Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Market Closed - Nasdaq Other stock markets 01:30:00 15/05/2024 am IST			5-day change	1st Jan Change
50.05 ^USD	-0.38%		-7.33%	+4.42%

11:14pm	Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer	MT
24/04	Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer	02:44am	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	25/04	MT
Korro Bio, Inc. Appoints Rachel Meyers as Board of Directors, Member of Nominating and Corporate Governance Committee	28/11	CI
Frequency Therapeutics, Inc. Announces the Resignation of Christopher Loose as Chief Scientific Officer	01/23/01	CI
Frequency Therapeutics, Inc. Announces Board Changes	11/23/11	CI
Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer	13/23/13	CI
Frequency Therapeutics, Inc. Announces Stepping Down of Carl P. Lebel, Ph.D. as Chief Development Officer, Effective March 31, 2023	13/23/13	CI
Actinogen Medical Appoints Medical Chief	01/23/01	MT
Voyager Therapeutics Names Peter Pfreundschuh Finance Chief	07/22/07	MT
Frequency Therapeutics, Inc. Appoints Kevin Franck as Senior Vice President of Strategic Marketing and New Product Planning	08/21/08	CI
Frequency Therapeutics Appoints Quentin McCubbin, Ph.D., as Chief Manufacturing Officer	19/21/19	CI
Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer	01/20/01	CI
Frequency Therapeutics Appoints Cynthia Feldmann to Its Board of Directors	25/20/25	CI
Frequency Therapeutics : Expands Leadership Team with Newly Appointed Chief People Officer and Head of Intellectual Property	10/20/10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Insiders

Filters